Zepp Health (NYSE:ZEPP – Get Free Report) has been assigned a $53.01 price objective by Fundamental Research in a research note issued to investors on Tuesday,BayStreet.CA reports. The firm presently has a “buy” rating on the stock.
Separately, Wall Street Zen downgraded shares of Zepp Health from a “hold” rating to a “sell” rating in a research report on Sunday, July 26th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Zepp Health presently has a consensus rating of “Hold” and a consensus price target of $53.01.
Get Our Latest Stock Report on Zepp Health
Zepp Health Stock Performance
Insider Activity at Zepp Health
In related news, CFO Cheng Deng sold 9,836 shares of Zepp Health stock in a transaction dated Friday, June 26th. The shares were sold at an average price of $4.61, for a total transaction of $45,343.96. Following the sale, the chief financial officer directly owned 114,539 shares in the company, valued at $528,024.79. The trade was a 7.91% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Company insiders own 36.00% of the company’s stock.
Hedge Funds Weigh In On Zepp Health
Several large investors have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio lifted its stake in shares of Zepp Health by 61.4% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock worth $41,000 after acquiring an additional 576 shares during the period. Osaic Holdings Inc. increased its stake in shares of Zepp Health by 239.5% during the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock valued at $223,000 after acquiring an additional 5,845 shares during the period. Dimensional Fund Advisors LP bought a new stake in Zepp Health during the fourth quarter worth approximately $241,000. Capstone Capital Management Ltd bought a new stake in Zepp Health during the fourth quarter worth approximately $298,000. Finally, Mangrove Partners IM LLC acquired a new stake in Zepp Health in the fourth quarter worth approximately $387,000. Institutional investors and hedge funds own 52.61% of the company’s stock.
About Zepp Health
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
Featured Stories
- Five stocks we like better than Zepp Health
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
